开源证券发布海圣医疗研报，北交所新股申购报告：麻醉监护医疗器械小巨人，麻醉监护精准化矩阵驱动成长

Group 1 - The core viewpoint of the report highlights that Haisheng Medical is recognized as a national-level specialized and innovative "little giant" in the field of anesthesia and monitoring medical devices [1] - The market size for low-value medical consumables is projected to reach 185.2 billion yuan in 2024, representing a 49% increase compared to the previous year [1] - The company possesses advantages in technology, including invasive blood pressure sensor packaging and bioelectrical signal acquisition, which lead industry advancements [1]